---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003135"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-04-08T23:59:59+00:00"
generated_at: "2026-05-23T19:17:53.261068+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health raises up to $2M via discounted equity; appoints three new directors

## Summary
- Equity purchase agreement with Triton Funds for up to $2M; first tranche 354,988 shares for $25,000.
- Subsequent purchases priced at 75% of lowest 5-day trading price before closing.
- Proceeds for commercial activities and working capital; subject to Nasdaq 19.99% limitation.
- Appointed new directors: Dr. Jeffrey Cohen, John Fraser, Cynthia Hundorfean (eff. Apr 2-6, 2025).
- Julie Carrillo appointed interim Principal Accounting Officer; Dr. Celeste Fralick departed Board.

## SEC filing metadata
- accession: 0001641172-25-003135
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-04-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003135
- JSON: https://secwatch.observer/filing/0001641172-25-003135.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003135.txt

## Key facts
- Executive change
  Cynthia Hundorfean was appointed as director at Aspira Women's Health Inc..
  - Action: appointed
  - Role: director
  source text: On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm
- Executive change
  John Fraser was appointed as director at Aspira Women's Health Inc..
  - Action: appointed
  - Role: director
  source text: On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm
- Executive change
  Jeffrey Cohen was appointed as director at Aspira Women's Health Inc..
  - Action: appointed
  - Role: director
  source text: On April 2, 2025, the Board (the “Board”) of Directors of the Company appointed Jeffrey Cohen, M.D. as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm
- Executive change
  Julie Carrillo was appointed as Principal Accounting Officer at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: On April 4, 2025, the Board appointed Julie Carrillo, the Company’s Corporate Controller, to act as the Principal Accounting Officer of the Company on an interim basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.